This article includes affiliate links to GLP-1 providers. We recommend these because we've vetted them. Any purchase through these links supports Peptide Base Lab at no extra cost to you.
Weight LossGLP-1 Explained: The Complete Scientific Guide to Weight Loss Peptides
GLP-1 receptor agonists produced the largest pharmacological weight loss results ever recorded outside of surgery. This guide covers what the molecule actually does in the body, what the registration trials measured, what the adverse event data looks like, and how to confirm the vial in your hand contains what the label claims.
What GLP-1 Is: The Hormone Before the Drug
Glucagon-like peptide-1 is an incretin hormone secreted by intestinal L-cells within minutes of eating. Native GLP-1 has a half-life of roughly two minutes because the enzyme DPP-4 cleaves it almost immediately. Every modern GLP-1 medication is a structurally modified analog engineered to resist that cleavage — semaglutide swaps one amino acid, adds a fatty-acid chain that binds albumin, and stretches the half-life to about a week.
Where the receptors are
GLP-1 receptors are expressed in pancreatic beta cells, the gastric antrum, the vagus nerve, and the arcuate nucleus of the hypothalamus. That distribution explains why one molecule affects insulin secretion, stomach emptying, and subjective hunger at the same time — they are not separate drug effects, they are one receptor in four tissues.
Why the modifications matter
The albumin-binding chain is the reason weekly dosing works. It is also the reason a counterfeit that contains generic peptide fragments rather than true semaglutide can produce almost no clinical effect: without the acylation, whatever is injected is cleared before it can act.
How GLP-1 Produces Weight Loss
Three mechanisms stack. Central appetite suppression reduces how much food feels necessary. Delayed gastric emptying extends fullness after a meal. Glucose-dependent insulin release blunts the post-meal crash that drives snacking. Caloric intake studies show a 24–35% reduction in ad libitum energy intake on therapeutic doses — the weight loss is overwhelmingly an intake effect, not a metabolic-rate effect.
The Clinical Trial Data
Two trial programs anchor the evidence base. STEP 1 randomized 1,961 adults without diabetes to semaglutide 2.4 mg weekly or placebo for 68 weeks and reported a mean body weight change of −14.9% versus −2.4%. SURMOUNT-1 tested tirzepatide 15 mg in 2,539 adults and reported up to −20.9%. SELECT then showed a 20% reduction in major adverse cardiovascular events over a mean 39.8 months in patients with established cardiovascular disease and obesity — the first hard-outcome result for this drug class in a non-diabetic population.
Reading the trials honestly
All four were manufacturer-funded, all used intensive lifestyle counseling in both arms, and all report means that hide wide individual spread. Roughly a third of STEP 1 participants lost more than 20%; a minority lost under 5%. Mean results are not a prediction for any single person.
What happens on discontinuation
STEP 4 is the most useful trial for expectation-setting: participants withdrawn from semaglutide regained about two-thirds of lost weight within a year. These are maintenance medications, not courses of treatment.
Side Effects and Who Should Avoid GLP-1
Gastrointestinal effects dominate: nausea in roughly 44% of STEP 1 participants, diarrhea in 30%, vomiting in 24%, constipation in 24%. Most are mild-to-moderate, cluster around dose escalation, and resolve within weeks. Serious events — pancreatitis, gallbladder disease, bowel obstruction — occur at low single-digit or sub-percent rates but are real. Personal or family history of medullary thyroid carcinoma or MEN 2 is an absolute contraindication based on rodent C-cell tumor findings, as is pregnancy.
Legal Access Routes
Branded semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are prescription-only. Telehealth platforms, primary care, and obesity medicine clinics are all legitimate prescribing routes. Compounded semaglutide occupied a large gray-to-legal space during the FDA shortage declaration, and that space narrows as shortages resolve. Research-chemical vendors selling vials labeled 'not for human consumption' are neither legal nor quality-controlled.
Why Verification Belongs in This Conversation
The verification problem scales with price. When a month of branded therapy costs four figures and an unregulated vial costs $40, counterfeiting becomes economically inevitable. In our own sample analysis, underdosing was more common than outright substitution — a vial that contains real semaglutide at 40% of the labeled concentration produces a plausible-feeling partial response and is nearly impossible to detect by feel. Photograph the vial and label before first use; that record is what makes later analysis possible.
Peptides 101, explained visually
Interactive diagrams for the concepts above. Tap through each stage.
Visual 1
From amino acids to peptides (the building-block explanation)
Stage 1 — separate blocks. Each circle is one amino acid. On their own they do nothing in particular. Think LEGO blocks in a box.
Animation showing individual coloured amino acid blocks linking together to form a peptide chain, then comparing a short peptide chain with a much longer protein chain.
Was this explanation clear?
Visual 2
How peptides work: the key-and-lock explanation
Scene 1 — the key. Your peptide. Its amino acid order gives it one specific shape, and that shape is the whole story.
Animation of a peptide drawn as a key travelling to a cell covered in receptor locks, sliding into a matching lock, and the cell then lighting up with different effects for GLP-1, BPC-157, TB-500 and NAD+.
Was this explanation clear?
Visual 3
Different peptides, different jobs
GLP-1
Metabolic / weight-management peptide
Job
Signals the gut and brain to slow eating and increase fullness
Reported result
- ↓ Appetite
- ↓ Body weight
- ↑ Fullness
BPC-157
Repair-signalling peptide (research only)
Job
Studied for angiogenesis and tissue repair signalling
Reported result
- ↑ Repair signalling (animal data)
- ↓ Reported pain
- Human data limited
TB-500
Recovery peptide (research only)
Job
Studied for cell migration and actin regulation
Reported result
- ↑ Reported recovery
- ↑ Range of motion claims
- No human trials
NAD+
Coenzyme, not strictly a peptide
Job
Feeds the cellular energy pathways that decline with age
Reported result
- ↑ Cellular energy substrate
- Mixed human outcomes
Educational summary only. Not medical advice, and not a recommendation to use any compound.
Infographic comparing GLP-1, BPC-157, TB-500 and NAD+ by what they are, what they signal, and the reported results, with a mascot icon for each.
Was this explanation clear?
Visual 4
Why peptide purity matters: 95% vs 50%
95% pure
Verified, correctly stored vial
95 units of active peptide per dose
Full expected effect ✓✓✓✓✓
50% pure
Underdosed, degraded or counterfeit vial
50 units of active peptide per dose
Roughly half the effect ✓✓
You are not getting what you paid for — and at the label dose you would never know. That is what verification is for.
Verify your peptides now →Side-by-side diagram of two 100-square dose grids: at 95 percent purity 95 squares are active peptide, at 50 percent purity only 50 are, meaning half the intended dose.
Was this explanation clear?
Visual 5
How storage affects your peptide
Refrigerated (2–8 °C)
100%
estimated potency
✓ Optimal
Room temperature counter
100%
estimated potency
✓ Optimal
Storage matters more than most people think. A vial that tested clean on arrival can still be under-strength by the time it reaches the last dose.
Interactive timeline comparing potency of a refrigerated peptide vial, which declines gradually from 100 percent to about 70 percent over a year, with a vial left at room temperature, which drops steeply within the first weeks.
Was this explanation clear?
Frequently Asked Questions
How does GLP-1 work for weight loss?
It activates GLP-1 receptors in the hypothalamus, stomach, and pancreas simultaneously — reducing hunger signaling, slowing gastric emptying, and flattening post-meal glucose. The net effect is a 24–35% reduction in spontaneous calorie intake.
How much weight can you lose on GLP-1?
Mean loss was 14.9% at 68 weeks in STEP 1 for semaglutide 2.4 mg and up to 20.9% at 72 weeks in SURMOUNT-1 for tirzepatide. Individual results range from under 5% to over 25%.
Is GLP-1 safe long term?
The SELECT trial followed 17,604 patients for a mean of roughly 40 months and found a cardiovascular benefit with no new safety signal. Data beyond five years is still accumulating.
Do you regain weight after stopping?
STEP 4 found participants regained about two-thirds of lost weight within a year of withdrawal. Sustained results require sustained treatment or a deliberate maintenance strategy.
References
Report a Safety Issue
If you've experienced health issues after using this peptide, please report it. Your report helps us track safety issues and protect other users.
Report Adverse Event